BioCardia, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
BioCardia, Inc. (BCDA) had Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized of 2.40 million shares as of 2013-12-31, per its 10-K filed 2014-03-24.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized · last filed 2014-03-24
- 2013-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 2.40M shares.
- 2013-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 2.40M shares.
- 2013-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 2.40M shares.
- 2013-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 2.40M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
|---|---|
| 2013-12-31 | 2.40M shares 10-K · filed 2014-03-24 |
| 2013-09-30 | 2.40M shares 10-Q · filed 2013-11-01 |
| 2013-06-30 | 2.40M shares 10-Q · filed 2013-07-26 |
| 2013-03-31 | 2.40M shares 10-Q · filed 2013-05-10 |
| 2012-12-31 | 2.40M shares 10-K · filed 2013-03-22 |
| 2012-09-30 | 2.40M shares 10-Q · filed 2012-11-08 |
| 2012-06-30 | 2.40M shares 10-Q · filed 2012-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |